Showing results (201-210 of 217) with videos related to

Sort By:
Pageof 22
Annals of Surgical Oncology|July 9, 2025
Oncological Resectability Criteria for Intrahepatic Cholangiocarcinoma: A Preoperative Framework for Multidisciplinary ManagementJun Kawashima, Miho Akabane, Selamawit Woldesenbet, et al.
Surgery|February 28, 2022
Nontumor related risk score: A new tool to improve prediction of prognosis after hepatectomy for colorectal liver metastasesKazunari Sasaki, Georgios Antonios Margonis, Amika Moro, et al.
Annals of Surgical Oncology|April 15, 2025
Impact of Tumor Size on the Survival Benefit of Anatomic Versus Non-Anatomic Resection for Intrahepatic CholangiocarcinomaJun Kawashima, Miho Akabane, Mujtaba Khalil, et al.
JAMA Surgery|March 30, 2022
Recipient and Donor Outcomes After Living-Donor Liver Transplant for Unresectable Colorectal Liver MetastasesRoberto Hernandez-Alejandro, Luis I Ruffolo, Kazunari Sasaki, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 16, 2025
Impact of intraoperative blood loss on postoperative morbidity after liver resection for primary and secondary liver cancerAbdullah Altaf, Miho Akabane, Mujtaba Khalil, et al.
JAMA Surgery|May 5, 2021
Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular CarcinomaKarim J Halazun, Russell E Rosenblatt, Neil Mehta, et al.
Surgery|September 23, 2023
An attempt to establish and apply global benchmarks for liver resection of malignant hepatic tumorsLaura Alaimo, Zorays Moazzam, Henrique A Lima, et al.
Annals of Surgical Oncology|October 16, 2024
Racial Disparities in Liver Transplant for Hepatitis C-Associated Hepatocellular CarcinomaFrances J Bennett, Jessica M Keilson, Michael K Turgeon, et al.
Ebiomedicine|May 28, 2025
Quantifying Flavin mononucleotide: an internationally validated methodological approach for enhanced decision making in organ transplantationKeyue Sun, Chunbao Jiao, Rebecca Panconesi, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
The Lipid Hydrolase ABHD6 is a Therapeutic Target in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Hepatocellular CarcinomaDanny Orabi, William J Massey, Kevin K Fung, et al.
Pageof 22